Julia Evans

Julia Evans covers health and medical news with an emphasis on research findings, public-health policy, healthcare developments, and significant scientific studies. She carefully reviews available evidence and seeks clear explanations of complex medical topics. Julia's approach is straightforward and measured, helping readers distinguish between established information, early research, expert interpretation, and claims that require further investigation.
Health

Kenya clears final Ebola case as DR Congo outbreak reaches 11,000

The Kenyan outbreak began on October 6 with the identification of the index case, a Kenyan man who had recently…

Read More »
Health

FDA Mandates New Eye Safety Warnings for GLP-1 Drugs Following Rare Vision Loss Data

The specific condition cited is non-arteritic anterior ischemic optic neuropathy (NAION). NAION is a relatively common cause of sudden, painless…

Read More »
Health

U.S. measles outbreak set to cost $83 million as elimination status at risk

Researchers at Johns Hopkins University have developed a new tool to estimate the financial burden of these outbreaks. Based on…

Read More »
Health

First Cold Health Alerts Issued as Arctic Air Brings Frost to England

The alerts, which cover the West Midlands and the north west of England, are in effect from 09:00 GMT on…

Read More »
Health

FDA mandates new vision-loss warning for popular GLP-1 diabetes and weight-loss drugs

NAION causes sudden, painless vision loss, typically in one eye. According to the FDA, there is currently no known treatment…

Read More »
Health

FDA Approves Updated High-Risk COVID-19 Vaccine Amidst Late-Summer Surge

Despite the renewed surge, the disease burden has diminished significantly since the pandemic began. As of early August 2026, fewer…

Read More »
Health

US Opioid Overdose Deaths Drop Sharply in 2024, Yet Remain Above Pre-Pandemic Levels

The recent downward trend follows a period of escalating mortality that began in 2017, when the opioid epidemic was declared…

Read More »
Health

Novartis Halts Development of Pelacarsen After Landmark Trial Fails

Apolipoprotein(a) is a protein that, when present at high levels in the blood, is strongly associated with an increased risk…

Read More »
Health

Australia approves Wegovy weight-loss pill, promising new option but with strict usage rules

The approval covers four strengths of the oral tablet: 1.5 mg, 4 mg, 9 mg, and 25 mg. The TGA…

Read More »
Health

WHO recommends two new Ebola vaccine candidates for DRC clinical trial as cases near 10,700

The two vaccine candidates slated for inclusion are ChAdOx1, developed by the University of Oxford and the Serum Institute of…

Read More »
Back to top button